Amgen (AMGN) has unveiled compelling new data showing its cholesterol-lowering drug Repatha significantly reduces the risk of death in high-risk cardiovascular patients. The findings, announced on 31 August 2026, come from a
More
The pharmaceutical distribution industry is closely watching the development of a national licensure standard that could reshape compliance requirements for wholesalers and third-party logistics providers. Kala Shankle, JD, Vice President of Regulatory
More
The Federal Circuit’s ruling in The Nielsen Company (US), LLC v. TVision Insights, Inc. offers a sharp warning to technology companies about the hidden costs of broad patent claims. The court affirmed
More
Maryland’s Family and Medical Leave Insurance programme, known as FAMLI, is now officially open for employer registration, with Governor Wes Moore urging swift action. Any business with at least one Maryland-based employee
More
Legal professionals gathered at ILTACON 2026 heard a clear message: superficial answers about AI adoption are no longer acceptable to sophisticated clients. Donovan Bell, a CLOC board member and former head of
More
The Minnesota State Fair has shattered multiple attendance records in its opening days, drawing massive crowds that dwarf figures from Trump’s Great American State Fair. The fair’s opening day on Thursday, August
More
The FTSE 100 opened broadly unchanged at 10,756.77 on 3 September 2026, with gains in precious-metal shares helping to offset persistent concerns over the Iran conflict. Gulf shipping disruptions and ongoing Middle
More
Wall Street futures are pointing lower as investors grow increasingly uneasy about the direction of inflation and its implications for interest rate policy. S&P 500 futures dipped in early trading as rising
More
Mid-cap stocks occupy a unique and often overlooked space in the market, sitting between the stability of large-caps and the growth potential of small-caps. Investors are frequently drawn to mid-cap companies because
More
A FTSE 250 defence company currently trading at just under £5 per share is being flagged as significantly undervalued by market watchers. The UK defence sector has attracted growing investor attention in
More